Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

122.65
-0.5900-0.48%
Volume:414.58K
Turnover:51.35M
Market Cap:13.26B
PE:270.36
High:126.38
Open:124.87
Low:122.01
Close:123.24
52wk High:126.38
52wk Low:28.66
Shares:108.10M
Float Shares:96.44M
Volume Ratio:0.62
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4537
EPS(LYR):0.8200
ROE:8.23%
ROA:0.47%
PB:18.79
PE(LYR):149.57

Loading ...

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

Corcept Therapeutics Director David L. Mahoney Sells 103,606 Shares Worth $12.26 Million

Reuters
·
Aug 21

Corcept Chief Business Officer Gary Charles Robb Sells 10,000 Shares for $1.16 Million

Reuters
·
Aug 19

Corcept Therapeutics Incorporated : Truist Securities Assumes Coverage with Buy Rating; Target Price $164 vs $50

THOMSON REUTERS
·
Aug 18

Truist Adjusts Price Target on Corcept Therapeutics to $164 From $50, Maintains Buy Rating

MT Newswires Live
·
Aug 18

Corcept Therapeutics Earnings Call Signals Accelerating Growth

TIPRANKS
·
Aug 18

Corcept Chief Development Officer William Guyer Disposes of Common Shares Worth $1.85 Million

Reuters
·
Aug 13

Corcept Therapeutics (CORT) Stock Could Be Undervalued Despite Mixed Broader Checks

Simply Wall St.
·
Aug 06

Corcept Chief Accounting & Technology Officer Joseph Douglas Lyon Disposes of 1,540 Common Shares Worth $175,806.40

Reuters
·
Aug 06

We Think That There Are More Issues For Corcept Therapeutics (NASDAQ:CORT) Than Just Sluggish Earnings

Simply Wall St.
·
Aug 05

Why Corcept Therapeutics (CORT) Is Up 19.8% After Boosting 2026 Revenue Guidance And Earnings

Simply Wall St.
·
Aug 04

Corcept CFO Atabak Mokari Sells 79,000 Shares Worth $8.95 Million

Reuters
·
Aug 04

3 High Growth Stocks Investors May Be Missing Right Now

Simply Wall St.
·
Aug 03

Coursera Stock And 2 More Growth Picks Backed By Healthy Balance Sheets

Simply Wall St.
·
Aug 02

OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts

TIPRANKS
·
Aug 01

LIVE Markets-us Earnings Forecast Jumps Further After Key Reports This Week

Reuters
·
Aug 01

Movement Alert|Corcept Therapeutics Falls 5.04% in Regular Trading, Profit-Taking After Prior Session Earnings-Driven Surge Amid Broad Pharma Weakness

Market Focus
·
Jul 31

Workday Stock And 2 Software Picks Backed By Insider Confidence

Simply Wall St.
·
Jul 31

Corcept Therapeutics Price Target Raised to $165.00/Share from $88.00 by Piper Sandler

Dow Jones
·
Jul 31

Corcept Therapeutics Shares Rally After Revenue Guidance Raised

Dow Jones
·
Jul 30